Table 1 . Disproportionality analysis (reporting odds ratio and its 95% confidence interval) of total neoplasms (cases) and more frequent cancers for each specific biological in VigiBase for the period between 2008 and 2020. ADR, adverse drug reactions; CI, confidence interval; ROR, reporting odds ratio.